{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:33:44Z","timestamp":1771605224689,"version":"3.50.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Ovarian cancer with breast metastasis is an exceedingly rare entity. We hereby reported a case of ovarian cancer presenting with synchronous breast metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>We report a case of a 39-year-old patient who was diagnosed with FIGO stage IV ovarian cancer, with pleural effusion and a suspected lesion in the breast. Biopsies of the breast lesion showed invasive carcinoma, immunohistochemistry stains of the breast biopsy specimen were positive for PAX-8, CA-125 markers, and negative for P53, SMA, Her2\/neu, Mammaglobin. Immunohistochemistry results combined with the diagnosis of ovarian cancer helped confirm the ovarian origin of breast tumor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>Ovarian cancer presenting with breast cancer metastasis concurrently is rare. The differential diagnosis between primary breast cancer and breast metastasis from ovarian cancer is challenging and immunohistochemistry results play a crucial role in establishing a definitive diagnosis in such cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Oncologist and pathologist should be able to identify this rare clinical scenario promptly for early diagnosis and treatment which relies on thorough examination, imaging and immunohistochemical studies. Nevertheless, owing to the extensive spread of the disease, the prognosis for this rare clinical scenario is generally poor.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002835","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T11:00:23Z","timestamp":1734606023000},"page":"393-397","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Ovarian cancer with breast metastasis: a rare case report"],"prefix":"10.1097","volume":"87","author":[{"given":"Tien Giang","family":"Dang","sequence":"first","affiliation":[{"name":"Department of Medical Oncology No. 6, Vietnam National Cancer Hospital, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Quang","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hanoi Medical University, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Hieu","family":"Khuc","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology No. 6, Vietnam National Cancer Hospital, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trung Toan","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vietnam National Cancer Hospital, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh Long","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology No. 6, Vietnam National Cancer Hospital, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20250926","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250926","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int J Surg"},{"key":"R3-20250926","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/cancers11081044","article-title":"Rare distant metastatic disease of ovarian and peritoneal carcinomatosis: a review of the literature","volume":"11","author":"Thomakos","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R4-20250926","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/1097-0142(20011101)92:9<2259::AID-CNCR1571>3.0.CO;2-O","article-title":"Secondary neoplasms of the breast: a survey of the 20th century","volume":"92","author":"Georgiannos","year":"2001","journal-title":"Cancer"},{"key":"R5-20250926","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/ijgc-00009577-200303000-00004","article-title":"Distant metastases in ovarian carcinoma","volume":"13","author":"Cormio","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20250926","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/00000478-200412000-00015","article-title":"Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall","volume":"28","author":"Recine","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R7-20250926","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1072-7515(98)00119-7","article-title":"Gynecologic cancers metastatic to the breast","volume":"187","author":"Moore","year":"1998","journal-title":"J Am Coll Surg"},{"key":"R8-20250926","doi-asserted-by":"crossref","first-page":"104081","DOI":"10.1016\/j.critrevonc.2023.104081","article-title":"Risk factors for developing both primary breast and primary ovarian cancer: a systematic review","volume":"190","author":"Ferris","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"R9-20250926","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3348\/kjr.2014.15.1.20","article-title":"Breast metastases from extramammary malignancies: typical and atypical ultrasound features","volume":"15","author":"Mun","year":"2014","journal-title":"Korean J Radiol"},{"key":"R10-20250926","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1101\/gad.240102","article-title":"Nephric lineage specification by Pax2 and Pax8","volume":"16","author":"Bouchard","year":"2002","journal-title":"Genes Dev"},{"key":"R11-20250926","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R12-20250926","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cncy.20089","article-title":"Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma","volume":"118","author":"McKnight","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"R13-20250926","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R14-20250926","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0028-2243(93)90131-U","article-title":"What do we know about the origin of CA 125?","volume":"49","author":"Bischof","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R15-20250926","first-page":"3028","article-title":"Mammaglobin expression in primary, metastatic, and occult breast cancer","volume":"59","author":"Watson","year":"1999","journal-title":"Cancer Res"},{"key":"R16-20250926","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12967-020-02295-y","article-title":"Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival","volume":"18","author":"Dabi","year":"2020","journal-title":"J Transl Med"},{"key":"R17-20250926","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R18-20250926","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.1996.4550","article-title":"Stage IV ovarian cancer: impact of surgical debulking","volume":"64","author":"Curtin","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R19-20250926","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1245\/s10434-011-2100-x","article-title":"Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer","volume":"19","author":"Rauh-Hain","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R20-20250926","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","author":"Perren","year":"2011","journal-title":"N Engl J Med"},{"key":"R21-20250926","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Gynecologic oncology group, incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N Engl J Med"},{"key":"R22-20250926","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejca.2016.09.036","article-title":"Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: results from the ANTHALYA trial","volume":"70","author":"Rouzier","year":"2017","journal-title":"Eur J Cancer"},{"key":"R23-20250926","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/ijgc-2019-000256","article-title":"Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer","volume":"29","author":"Garcia Garcia","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"R24-20250926","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/cncr.22835","article-title":"Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival","volume":"110","author":"Williams","year":"2007","journal-title":"Cancer"},{"key":"R25-20250926","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ygyno.2006.01.056","article-title":"Ovarian cancer metastatic to the breast","volume":"102","author":"Micha","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R26-20250926","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00000421-199908000-00018","article-title":"Bilateral inflammatory breast metastases of epithelial ovarian cancer","volume":"22","author":"Ozg\u00fcro\u011flu","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"R27-20250926","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/modpathol.2012.191","article-title":"Non-mammary metastases to the breast and axilla: a study of 85 cases","volume":"26","author":"DeLair","year":"2013","journal-title":"Mod Pathol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:00:34Z","timestamp":1758873634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002835","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-09-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}